ICCC
ImmuCell Corporation
NASDAQ · Healthcare · Biotechnology · US
$9.90
−1.00%Leverage
- Debt / equity
- 0.40x
- Net debt / equity
- 0.11x
- Debt / assets
- 0.27x
- Debt / EBITDA
- 3.52x
- Net debt / EBITDA
- 1.01x
Liquidity & coverage
- Current ratio
- 4.75x
- Quick ratio
- 2.71x
- Cash ratio
- 2.00x
- Interest coverage
- 8.93x
- EBITDA / interest
- 8.17x
- Working capital
- $16.6M
Cash & dividend
- FCF / debt
- 0.34x
- Cash flow / debt
- 0.47x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026